Whiteboard Doctor
Anti-viral drug found to potentially decrease the risk of developing Long COVID, also known as Post Acute Sequelae of COVID-19 (PASC).
New study out on Nirmatrelvir-Ritonavir, brand name Paxlovid. They found that in those who received Paxlovid during their acute COVID-19 infection there was a 25% decreased risk of developing Long COVID and also a decrease risk of death and hospitalization at 90 days.
Beyond that, they found a decreased risk of developing 10 of 12 Long COVID symptoms including abnormal heart rhythms, ischemic heart disease, neurocognitive dysfunction, blood clots of the lung called pulmonary embolism, blood clots of the leg called deep vein thrombosis, liver disease, kidney disease, and more! https://www.medrxiv.org/content/10.11…
Playlist on me having Omicron! https://youtube.com/playlist?list=PLf…
Playlist on COVID-19 Variants! https://youtube.com/playlist?list=PLf…
COVID-19 Pathophysiology Playlist: https://youtube.com/playlist?list=PLf…
Playlist with all videos on Long COVID: https://youtube.com/playlist?list=PLf…
DISCLAIMER:
THIS VIDEO DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.